Acute hyperglycemia produces transient improvement in glucose transporter type 1 deficiency

Annals of Neurology

Volumn 67, Issue 1, 2010, Pages 31-40

  Akman, Cigdem I ^a   Engelstad, Kristin ^b   Hinton, Veronica J ^c   Ullner, Paivi ^b   Koenigsberger, Dorcas ^b   Leary, Linda ^b   Wang, Dong ^b   De Vivo, Darryl C ^b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b Taub Institute for Research on Alzheimer's Disease and the Aging Brain and the Gertrude H Sergievsky Center   (United States)

^c NewYork Presbyterian Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GLUCOSE TRANSPORTER 1; INSULIN;

ADOLESCENT; ADULT; ARTICLE; ATTENTION; BRAIN DISEASE; BRAIN FUNCTION; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; ELECTROENCEPHALOGRAM; ENERGY METABOLISM; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; GLUCOSE TRANSPORT; GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME; HUMAN; HYPERGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN RESPONSE; MALE; MEMORY; MOTOR COORDINATION; NEUROPSYCHOLOGICAL TEST; ORAL GLUCOSE TOLERANCE TEST; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHOOL CHILD; SEIZURE; WELLBEING;

ACUTE DISEASE; ADOLESCENT; ADULT; BLOOD GLUCOSE; BRAIN; CHILD; FEMALE; GLUCOSE TOLERANCE TEST; GLUCOSE TRANSPORTER TYPE 1; HUMANS; HYPERGLYCEMIA; INSULIN; MALE; NEUROPSYCHOLOGICAL TESTS; PROSPECTIVE STUDIES; SEIZURES; SYNDROME; TIME FACTORS; YOUNG ADULT;

EID: 77649303044     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.21797     Document Type: Article

References (43)

1. De Vivo DC, Leary L, Wang D. Glucose transporter 1 deficiency syndrome and other glycolytic defects. J Child Neurol 2002; 17(suppl 3):3S15-3S23; discussion 3S24-3S25.
2. De Vivo DC, Trifiletti RR, Jacobson RI, et al. Defective glucose transport across the blood-brain barrier as a cause of persistent hypoglycorrhachia, seizures, and developmental delay [see comment]. N Engl J Med 1991;325:703-709.
3. De Vivo DC, Wang D. Glut1 deficiency: CSF glucose. How low is too low? Rev Neurol (Paris) 2008;164:877-880.
4. De Vivo DC, Wang D, Pascual JM. Disorders of glucose transport. In: Rosenberg RN, DiMauro S, Paulson, HL, Ptáĉek L, Nestler EJ, eds. The Molecular and Genetic Basis of Neurologic and Psychiatric Diseases. 4th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2008:653-662.
5. Owen OE, Morgan AP, Kemp HG, et al. Brain metabolism during fasting. J Clin Invest 1967;46:1589-1595.
6. Nordli DR Jr, Kuroda MM, Carroll J, et al. Experience with the ketogenic diet in infants. Pediatrics 2001;108:129-133.
7. DeVivo DC, Leckie MP, Ferrendelli JS, McDougal DB Jr. Chronic ketosis and cerebral metabolism. Ann Neurol 1978;3:331-337.
8. Brockmann K, Wang D, Korenke CG, et al. Autosomal dominant glut-1 deficiency syndrome and familial epilepsy. Ann Neurol 2001;50:476-485.
9. Pascual JM, Wang D, Hinton V, et al. Brain glucose supply and the syndrome of infantile neuroglycopenia. Arch Neurol 2007;64: 507-513.
10. Wang DYH, Shi L, Ma L, et al. Functional studies of the T295M mutation causing Glut-1 deficiency: glucose efflux preferentially affected by T295M. Pediatr Res 2008;64:538-543.
11. Kaufmann P, Shungu DC, Sano MC, et al. Cerebral lactic acidosis correlates with neurological impairment in MELAS. Neurology 2004;62:1297-1302.
12. Reitan RM, Wolfson D. The Halstead-Reitan Neuropsychological Test Battery: Theory and Clinical Interpretation. Tuscon, AZ: Neuropsychology Press; 1993.
13. Wechsler D. Wechsler Intelligence Scale for Children-III (WISC-III) Manual. San Antonio, TX: The Psychological Corporation, Harcourt Brace and Company; 1991.
14. Brandt J. The Hopkins Verbal Learning Test: development of a new verbal memory test with six equivalent forms. Clin Neuropsychol 1991;5:125-142.
15. Barros LF, Bittner CX, Loaiza A, Porras OH. A quantitative overview of glucose dynamics in the gliovascular unit. Glia 2007;55: 1222-1237.
16. Vannucci SJ, Maher F, Koehler E, Simpson IA. Altered expression of GLUT-1 and GLUT-3 glucose transporters in neurohypophysis of water-deprived or diabetic rats. Am J Physiol 1994;267: E605-E611.
17. Lee WJ, Peterson DR, Sukowski EJ, Hawkins RA. Glucose transport by isolated plasma membranes of the bovine blood-brain barrier. Am J Physiol 1997;272:C1552-C1557.
18. Simpson IA, Vannucci SJ, DeJoseph MR, Hawkins RA. Glucose transporter asymmetries in the bovine blood-brain barrier. J Biol Chem 2001;276:12725-12729.
19. Anderson MS, Flowers-Ziegler J, Das UG, et al. Glucose transporter protein responses to selective hyperglycemia or hyperinsulinemia in fetal sheep. Am J Physiol Regul Integr Comp Physiol 2001;281:R1545-R1552.
20. Choi IY, Lee SP, Kim SG, Gruetter R. In vivo measurements of brain glucose transport using the reversible Michaelis-Menten model and simultaneous measurements of cerebral blood .ow changes during hypoglycemia. J Cereb Blood Flow Metab 2001; 21:653-663.
21. Duelli R, Maurer MH, Staudt R, et al. Increased cerebral glucose utilization and decreased glucose transporter Glut1 during chronic hyperglycemia in rat brain. Brain Res 2000;858:338-347.
22. Hasselbalch SG, Knudsen GM, Capaldo B, et al. Blood-brain barrier transport and brain metabolism of glucose during acute hyperglycemia in humans. J Clin Endocrinol Metab 2001;86: 1986-1990.
23. Simpson IA, Appel NM, Hokari M, et al. Blood-brain barrier glucose transporter: effects of hypo- and hyperglycemia revisited. J Neurochem 1999;72:238-247.
24. Banks WA. The source of cerebral insulin. Eur J Pharmacol 2004; 490:5-12.
25. Schwartz JG, Phillips WT, Aghebat-Khairy B. Revision of the oral glucose tolerance test: a pilot study [see comment]. Clin Chem 1990;36:125-128.
26. Bingham EM, Hopkins D, Smith D, et al. The role of insulin in human brain glucose metabolism: an 18fluoro-deoxyglucose positron emission tomography study. Diabetes 2002;51: 3384-3390.
27. McEwen BS, Reagan LP. Glucose transporter expression in the central nervous system: relationship to synaptic function. Eur J Pharmacol 2004;490:13-24.
28. Verleysdonk S, Hirschner W, Wellard J, et al. Regulation by insulin and insulin-like growth factor of 2-deoxyglucose uptake in primary ependymal cell cultures. Neurochem Res 2004;29: 127-134.
29. Wang D, Pascual JM, Yang H, et al. A mouse model for Glut-1 haploinsufficiency. Hum Mol Genet 2006;15:1169-1179.
30. Leary LD, Wang D, Nordli DR Jr, et al. Seizure characterization and electroencephalographic features in Glut-1 deficiency syndrome. Epilepsia 2003;44:701-707.
31. Boles RG, Seashore MR, Mitchell WG, et al. Glucose transporter type 1 deficiency: a study of two cases with video-EEG. Eur J Pediatr 1999;158:978-983.
32. Von Moers A, Brockmann K, Wang D, et al. EEG features of glut-1 de.ciency syndrome. Epilepsia 2002;43:941-945. 33. Bjorgaas M, Sand T, Vik T, Jorde R. Quantitative EEG during controlled hypoglycaemia in diabetic and non-diabetic children. Diabet Med 1998;15:30-37.
33. Hyllienmark L, Maltez J, Dandenell A, et al. EEG abnormalities with and without relation to severe hypoglycaemia in adolescents with type 1 diabetes [see comment]. Diabetologia 2005;48: 412-419.
34. Harrad RA, Cockram CS, Plumb AP, et al. The effect of hypoglycaemia on visual function: a clinical and electrophysiological study. Clin Sci 1985;69:673-679.
35. Lopes da Silva F. Neural mechanisms underlying brain waves: from neural membranes to networks. Electroencephalogr Clin Neurophysiol 1991;79:81-93.
36. Lindgren KA, Larson CL, Schaefer SM, et al. Thalamic metabolic rate predicts EEG alpha power in healthy control subjects but not in depressed patients. Biol Psychiatry 1999;45:943-952.
37. Goldman RI, Stern JM, Engel J Jr, Cohen MS. Simultaneous EEG and fMRI of the alpha rhythm. Neuroreport 2002;13:2487-2492.
38. Feige B, Schef.er K, Esposito F, et al. Cortical and subcortical correlates of electroencephalographic alpha rhythm modulation. J Neurophysiol 2005;93:2864-2872.
39. Schreckenberger M, Lange-Asschenfeldt C, Lochmann M, et al. The thalamus as the generator and modulator of EEG alpha rhythm: a combined PET/EEG study with lorazepam challenge in humans. Neuroimage 2004;22:637-644; erratum 2006;32:485.
40. Hughes SW, Crunelli V. Thalamic mechanisms of EEG alpha rhythms and their pathological implications. Neuroscientist 2005; 11:357-372.
41. Pascual JM, Van Heertum RL, Wang D, et al. Imaging the metabolic footprint of Glut1 de.ciency on the brain. Ann Neurol 2002;52:458-464.
42. Suls A, Dedeken P, Gof.n K, et al. Paroxysmal exercise-induced dyskinesia and epilepsy is due to mutations in SLC2A1, encoding the glucose transporter GLUT1. Brain 2008;131:1831-1844.
43. Weber YG, Storch A, Wuttke TV, et al. GLUT1 mutations are a cause of paroxysmal exertion-induced dyskinesias and induce hemolytic anemia by a cation leak. J Clin Invest 2008;118: 2157-2168.